🟢 Veradermics is trading 4.4% up today on broader biotech sector strength

Veradermics is trading 4.4% up at $111.95 today, tracking a broader upswing across the biotechnology sector rather than stock-specific news.

• The move extends yesterday’s sharp rebound and follows recent post-IPO volatility, despite a lack of fresh company headlines on August 5.
• Gains are largely attributed to sector-wide momentum, with the XBI biotech ETF rising approximately 2% on solid earnings and a risk-on sentiment across the healthcare space.